Influenza A virus H1N1 vaccine intranasal - BioDiem/Serum Institute of India

Drug Profile

Influenza A virus H1N1 vaccine intranasal - BioDiem/Serum Institute of India

Alternative Names: LAIV influenza A vaccine H1N1 - SII; Live-attenuated influenza virus vaccine H1N1; Nasovac; Pandemic influenza A H1N1 - intranasal

Latest Information Update: 04 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
  • Developer Serum Institute of India
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 31 Jul 2010 Launched for Influenza-A virus H1N1 subtype in India (Intranasal)
  • 10 Jul 2010 The Serum Institute of India completes a phase II/III trial in Influenza-A virus H1N1 (prevention, in paediatric, adult and elderly volunteers) in India
  • 10 Jul 2010 The Serum Institute of India completes a phase I trial in Influenza-A virus H1N1 (prevention, in volunteers) in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top